Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05021055
Other study ID # 6077
Secondary ID 4927
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2021
Est. completion date July 2022

Study information

Verified date July 2021
Source Hospital Italiano de Buenos Aires
Contact Andrés Brandan
Phone +5493816212804
Email andres.brandan@hospitalitaliano.org.ar
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. These systems are designed to aid healthcare professional decision making. In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed.


Description:

The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Consequently, in clinical practice, breast density is reported from the assessment carried out by specialists with the support of these systems. But there are few studies about the use, concordance and perception of usefulness of professionals on these tools. A study carried out at the Hospital Italiano de Buenos Aires reported a moderate to almost perfect inter- and intra-observer agreement among radiologists and a moderate concordance between the categorization carried out by experts and that carried out by commercial software of a digital mammography machine. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. Once a system designed to aid healthcare professional decision making is developed, it must be validated. In 2019, an internal validation of a tool based on deep learning techniques was carried out for the automatic categorization of mammographic breast density. The tool reached a very good interobserver agreement, kappa = 0.64 (95% CI 0.58-0.69), when compared with the performance of the professionals. It reached a sensitivity of 83.2 (CI: 76.9-88.3) and a specificity of 88.4 (83.9-92.0.) In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed. The evaluation of this tool will be carried out in two external institutions: Hospital Alemán and Fundación Científica del Sur.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 277
Est. completion date July 2022
Est. primary completion date April 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Mammograms included in the study should meet the following criteria: - Female patients of 40 years of age or more. - To have at least one screening mammography exam performed at Saint John's - Cancer Institute during the study period. These exams will be included regardless of the brand of the mammography equipment. - Mammograms should be performed with digital equipment. Exclusion Criteria: - Mammograms with the following criteria will be excluded from the study: - Patients with gigantomastia, defined by the need for more than one image of each mammographic view (mediolateral oblique and craniocaudal) to evaluate the entire breast volume. - Patients with breast implants. - Patients with a history of breast surgery.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hospital Italiano de Buenos Aires

References & Publications (22)

A L Mousa DS, Ryan EA, Mello-Thoms C, Brennan PC. What effect does mammographic breast density have on lesion detection in digital mammography? Clin Radiol. 2014 Apr;69(4):333-41. doi: 10.1016/j.crad.2013.11.014. Epub 2014 Jan 11. Review. — View Citation

Alikhassi A, Esmaili Gourabi H, Baikpour M. Comparison of inter- and intra-observer variability of breast density assessments using the fourth and fifth editions of Breast Imaging Reporting and Data System. Eur J Radiol Open. 2018 Apr 20;5:67-72. doi: 10.1016/j.ejro.2018.04.002. eCollection 2018. — View Citation

Alonzo-Proulx O, Jong RA, Yaffe MJ. Volumetric breast density characteristics as determined from digital mammograms. Phys Med Biol. 2012 Nov 21;57(22):7443-57. doi: 10.1088/0031-9155/57/22/7443. Epub 2012 Oct 24. — View Citation

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007 Jan 18;356(3):227-36. — View Citation

Carreira Gómez MC, Estrada Blan MC. What we need to know about dense breasts: implications for breast cancer screening. Radiologia. 2016 Nov - Dec;58(6):421-426. doi: 10.1016/j.rx.2016.08.002. Epub 2016 Oct 15. English, Spanish. — View Citation

Ciatto S, Bernardi D, Calabrese M, Durando M, Gentilini MA, Mariscotti G, Monetti F, Moriconi E, Pesce B, Roselli A, Stevanin C, Tapparelli M, Houssami N. A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast. 2012 Aug;21(4):503-6. doi: 10.1016/j.breast.2012.01.005. Epub 2012 Jan 27. — View Citation

Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004 Jan 26;90(2):393-6. — View Citation

Do S, Song KD, Chung JW. Basics of Deep Learning: A Radiologist's Guide to Understanding Published Radiology Articles on Deep Learning. Korean J Radiol. 2020 Jan;21(1):33-41. doi: 10.3348/kjr.2019.0312. Review. — View Citation

Dontchos BN, Yala A, Barzilay R, Xiang J, Lehman CD. External Validation of a Deep Learning Model for Predicting Mammographic Breast Density in Routine Clinical Practice. Acad Radiol. 2021 Apr;28(4):475-480. doi: 10.1016/j.acra.2019.12.012. Epub 2020 Feb 20. — View Citation

Eom HJ, Cha JH, Kang JW, Choi WJ, Kim HJ, Go E. Comparison of variability in breast density assessment by BI-RADS category according to the level of experience. Acta Radiol. 2018 May;59(5):527-532. doi: 10.1177/0284185117725369. Epub 2017 Aug 2. — View Citation

Gao J, Warren R, Warren-Forward H, Forbes JF. Reproducibility of visual assessment on mammographic density. Breast Cancer Res Treat. 2008 Mar;108(1):121-7. Epub 2007 Jul 7. — View Citation

Jeffers AM, Sieh W, Lipson JA, Rothstein JH, McGuire V, Whittemore AS, Rubin DL. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS. Radiology. 2017 Feb;282(2):348-355. doi: 10.1148/radiol.2016152062. Epub 2016 Sep 5. — View Citation

Liu Y, Chen PC, Krause J, Peng L. How to Read Articles That Use Machine Learning: Users' Guides to the Medical Literature. JAMA. 2019 Nov 12;322(18):1806-1816. doi: 10.1001/jama.2019.16489. — View Citation

Martínez Gómez I, Casals El Busto M, Antón Guirao J, Ruiz Perales F, Llobet Azpitarte R. Semiautomatic estimation of breast density with DM-Scan software. Radiologia. 2014 Sep-Oct;56(5):429-34. doi: 10.1016/j.rx.2012.11.007. Epub 2013 Mar 13. English, Spanish. — View Citation

McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69. — View Citation

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Feb 16;164(4):268-78. doi: 10.7326/M15-1789. Epub 2016 Jan 12. Review. — View Citation

Pesce K, Tajerian M, Chico MJ, Swiecicki MP, Boietti B, Frangella MJ, Benitez S. Interobserver and intraobserver variability in determining breast density according to the fifth edition of the BI-RADS® Atlas. Radiologia (Engl Ed). 2020 Nov - Dec;62(6):481-486. doi: 10.1016/j.rx.2020.04.006. Epub 2020 May 31. English, Spanish. — View Citation

Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE; PROSPR Consortium. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med. 2016 Oct 4;165(7):457-464. doi: 10.7326/M15-2934. Epub 2016 Jul 19. — View Citation

Strand F, Azavedo E, Hellgren R, Humphreys K, Eriksson M, Shepherd J, Hall P, Czene K. Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study. Breast Cancer Res. 2019 Jan 22;21(1):8. doi: 10.1186/s13058-019-1099-y. — View Citation

Swann CA, Kopans DB, McCarthy KA, White G, Hall DA. Mammographic density and physical assessment of the breast. AJR Am J Roentgenol. 1987 Mar;148(3):525-6. — View Citation

Wanders JOP, Holland K, Karssemeijer N, Peeters PHM, Veldhuis WB, Mann RM, van Gils CH. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study. Breast Cancer Res. 2017 Jun 5;19(1):67. doi: 10.1186/s13058-017-0859-9. — View Citation

Winkler NS, Raza S, Mackesy M, Birdwell RL. Breast density: clinical implications and assessment methods. Radiographics. 2015 Mar-Apr;35(2):316-24. doi: 10.1148/rg.352140134. — View Citation

* Note: There are 22 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement between the majority report and Artemisia´s categorization of dense breasts/non-dense breasts The agreement between the CNN and the total of the professionals' categorizations will be calculated with the linear weighted kappa. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images. 2 months
Primary Agreement between the majority report and Artemisia in each one of the four breast density categories For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images. 2 months
Secondary Agreement between each observer and Artemisia´s categorization of dense breasts/non-dense breasts To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images. 2 months
Secondary Agreement between each observer and Artemisia in each one of the four breast density categories For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images. 2 months
Secondary Agreement between each observer and the majority report in the categorization of dense breasts/non-dense breasts For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images. 2 months
Secondary Agreement between each observer and the majority report in each one of the four breast density categories For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images. 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A